These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2989637

  • 1. Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways.
    Beck FW, Sowers JR, Sicca D, Welch BG.
    Life Sci; 1985 Jun 24; 36(25):2435-44. PubMed ID: 2989637
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR, Beck FW.
    Acta Endocrinol (Copenh); 1983 Feb 24; 102(2):258-64. PubMed ID: 6338674
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
    Sowers JR, Berg G, Martin VS, Mayes DM.
    Endocrinology; 1982 Apr 24; 110(4):1173-7. PubMed ID: 7060520
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoid suppression enhances the 18-hydroxycorticosterone and aldosterone response to metoclopramide in man.
    Sowers JR, Beck FW, Stern N.
    Life Sci; 1983 Dec 19; 33(25):2489-95. PubMed ID: 6645810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR, Eggena P, Phillips D.
    Metabolism; 1982 Dec 19; 31(12):1219-23. PubMed ID: 7144566
    [Abstract] [Full Text] [Related]

  • 8. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR, Berg G, Tuck ML, Martin VI, Chandler DW, Mayes DM.
    J Clin Endocrinol Metab; 1982 Mar 19; 54(3):523-7. PubMed ID: 7035483
    [Abstract] [Full Text] [Related]

  • 9. Effect of metoclopramide on the secretion of aldosterone and other adrenocortical steroids.
    Nagahama S, Fujimaki M, Kawabe H, Nakamura R, Saito I, Saruta T.
    Clin Endocrinol (Oxf); 1983 Mar 19; 18(3):287-93. PubMed ID: 6861367
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone suppression with dopamine infusion in low-renin hypertension.
    Holland OB, Thomas C, Brown H, Schindewolf D, Hillier Y, Gomez-Sanchez C.
    J Clin Invest; 1983 Sep 19; 72(3):754-66. PubMed ID: 6309909
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G, Catt KJ.
    Endocrinology; 1984 Jan 19; 114(1):176-81. PubMed ID: 6317344
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies].
    Ojima M, Itoh N, Kusano Y, Yaginuma K, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1986 Mar 20; 62(3):197-207. PubMed ID: 3709883
    [Abstract] [Full Text] [Related]

  • 20. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K, Yamazaki M, Ikeda K, Yaginuma K, Hashimoto S, Fukuchi S.
    Jpn Heart J; 1983 Nov 20; 24(6):917-24. PubMed ID: 6323781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.